Jan 4 (Reuters) - Allergan (N:AGN_pa) plc AGN.N :
* Allergan and Perrigo announce first-to-market launch of store brand
equivalent to mucinex d 600mg er tablets
* Says Perrigo announced the temporary suspension of sales of its guaifenesin
600mg
* Says first shipments of new store branded product started in December
* Says suspension is expected to have a minimal impact to perrigo's fourth
quarter 2015 adjusted earnings per share
* Perrigo's suspension of product pending resolution of challenges related to
an excipient used in the production of the product
* To launch the balance of range of 5 additional mucinex-comparable products
to U.S. store brand market over the course of H1 2016
* Source text for Eikon ID:nPn1pBgL8
* Further company coverage AGN.N